D3 Oncology Solutions
RELATED CONTENT
November 9, 2012 — The team of dosimetrists and physicists at D3 Oncology Solutions (D3), an affiliate of UPMC and UPMC CancerCenter, recently surpassed significant milestones: completing its 30,000th advanced treatment plan and commissioning its 100th linear accelerator.
November 09, 2012 
July 27, 2011 — D3 Oncology Solutions announced that it will begin offering a comprehensive product to radiation oncologists and surgeons to rapidly and safely implement a successful stereotactic radiosurgery/stereotactic body radiation therapy (SRS/SBRT) program.
July 27, 2011 
May 26, 2011 - D3 Oncology Solutions announced that it will provide its Via Oncology Pathways for a six-month free trial period to enable cancer programs to align the timing of their investment with a strategy for sharing potential savings with payors and other key stakeholders.
May 26, 2011